Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

JNJ 100.14 -1.01 (-1.00%)
price chart
Johnson & Johnson Campaign for Nursings Future turns 10
Ten years ago a nursing shortage loomed in the United States. A shortfall of about 400,000 nurses by 2020 was projected and, between 1983 and 1998, the proportion of RNs younger than 30 had dropped from 30% to 12%, according to a 2000 article in the ...
Warren Buffett Buys More Wells Fargo and IBM, Sells Johnson & Johnson
But Warren Buffett did buy more of his favorite companies Wells Fargo and IBM, and sold Johnson & Johnson during the third quarter.
Warren Buffett Buys Deere and Wabco; Sells Johnson & Johnson and P&G  ValueWalk
Berkshire Dumps Most of J&J and GE Stakes; Adds Deere & Co.
Johnson & Johnson Reaches Settlement in 845 Levaquin Cases
Nov. 1 (Bloomberg) -- Johnson & Johnson settled lawsuits with about 845 plaintiffs who claimed the drugmaker didn't properly warn of the risks of tendon damage from its antibiotic Levaquin.
Dr. Buffett Has Diagnosed Johnson & Johnson As Too Big To Succeed
We are amazed that Johnson & Johnson's (NYSE:JNJ) shares have held up better than the S&P 500 over the last month.
Johnson & Johnson Elects CEO Gorsky Chairman
Johnson & Johnson (JNJ) said it elected new CEO Alex Gorsky as chairman on Friday, replacing Bill Weldon who will step down later this year with plans to retire in the first quarter of 2013.
Johnson & Johnson Chief Gorsky Elected to Chairman  Bloomberg
Weldon passes baton at Johnson & Johnson to Gorsky
J&J says it won't enforce AIDS drug patent in Africa
LONDON Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson's HIV/AIDS drug Prezista for sale in Africa and other poor countries.
Johnson & Johnson, Merck and Eli Lilly to rip red tape from clinical trials
Johnson & Johnson's ($JNJ) Janssen R&D unit is leading a charge to expedite the tedious process of selecting sites for clinical trial sites, with the creation of a investigator database intended to get studies up and running more efficiently.
J&J, Lilly, Merck plan clinical trial site database  Reuters
Johnson & Johnson One-Ups Tuberculosis
In an 18-0 ruling on efficacy, the FDA advisory committee voted in favor of Johnson & Johnson's bedaquiline, a drug to combat multidrug-resistant tuberculosis.
Johnson & Johnson Family of Diabetes Companies Provides Diabetes Supplies ...
Five companies comprise the Johnson & Johnson Family of Diabetes Companies with the shared vision of "Creating a world without limits for people with diabetes.
J&J's Global Media Review Hits Halfway Mark
Johnson & Johnson is midway through a global review of its media planning and buying business with its decision in the North American market this week.